A recent analysis of 51 patients revealed that contrast-enhanced mammography and MRI offered comparable assessments of lesion size, and both had similar specificity for pathologic complete response.

"Our model is a potential tool to improve the primary trisomy 21 screening based on ultrasonographic images for universal clinical application," experts involved in the study suggested.

A nonprofit healthcare-certification organization is challenging every user of medical ultrasound in the world to become proficient and certified in the modality by 2030.

There are many known disparities in breast imaging that have been found in previous studies, but insight into diagnostic mammography processes is still lacking. 

For the research, special attention was paid to women with dense breasts and other factors that raise their risk of a breast cancer diagnosis.

The study yielded a malignancy rate of 8.4% for the women who presented for routine pelvic ultrasound without prior suspicion for adnexal lesions.

COVID-19 set back screening mammography further than any other category of breast care, dropping schedule adherence during infection peaks to 36% of pre-pandemic rates.

In addition to CE-MRI's increased sensitivity for identifying breast cancers, the researchers also found the modality had superior negative likelihood ratios with higher pre-test probabilities for safely ruling out malignancy.